Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors.

Stevens KL, Alligood KJ, Alberti JG, Caferro TR, Chamberlain SD, Dickerson SH, Dickson HD, Emerson HK, Griffin RJ, Hubbard RD, Keith BR, Mullin RJ, Petrov KG, Gerding RM, Reno MJ, Rheault TR, Rusnak DW, Sammond DM, Smith SC, Uehling DE, Waterson AG, Wood ER
Bioorg Med Chem Lett. 2009 19 (1): 21-6

PMID: 19028424 · DOI:10.1016/j.bmcl.2008.11.023

A novel class of pyrrolidinyl-acetyleneic thieno[3,2-d]pyrimidines has been identified which potently inhibit the EGFR and ErbB-2 receptor tyrosine kinases. Synthetic modifications of the pyrrolidine carbamate moiety result in a range of effects on enzyme and cellular potency. In addition, the impact of the absolute stereochemical configuration on cellular potency and oral mouse pharmacokinetics is described.

MeSH Terms (10)

Administration, Oral Animals Antineoplastic Agents ErbB Receptors Mice Pharmacokinetics Pyrimidines Pyrrolidines Receptor, ErbB-2 Structure-Activity Relationship

Connections (1)

This publication is referenced by other Labnodes entities: